Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Dupixent, FDA and COPD
FDA Approves Dupixent Injections For People Struggling With COPD Symptoms
The FDA has approved Dupixent (dupilumab) as an add-on therapy for adults with poorly controlled COPD, especially those with elevated eosinophil levels. Clinical trials show that Dupixent reduces COPD exacerbations and improves symptoms when combined with inhaled medications,
FDA approves Dupixent for chronic obstructive pulmonary disease
The U.S. Food and Drug Administration has approved Regeneron's Dupixent (dupilumab) as an add-on maintenance treatment for adults with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype.
FDA Approves Dupixent for Some Patients Struggling With COPD Symptoms
Dupixent may help some people with inadequately controlled COPD who have a type of lung inflammation that worsens symptoms.
Yahoo Finance
6d
Dupixent® (dupilumab) Approved in China as the First-ever Biologic Medicine for Patients with Chronic Obstructive Pulmonary Disease (COPD)
Dupixent
is available in China in a 300 mg dose as a pre-filled syringe or pre-filled pen and is now available for
COPD
.
Dupixent
is intended for injection under the skin (subcutaneous injection ...
6d
Press Release: Dupixent approved in China as the first-ever biologic medicine for patients with COPD
Dupixent approved in China as the first-ever biologic medicine for patients with COPDApproval follows EU approval of Dupixent for adults with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
US port strike ends
Helene's wake
To be closed indefinitely
Sentenced to 9 yrs in prison
Ex-Memphis cops guilty
TikTok star charged
Accused of sexual assault
Kirk becomes Category 4
Fifth recall within a year
'Rust' gets premiere date
Texas AG sues TikTok
California gang busted
Mortgage rate ticks up
Student loan plan ruling
FDA: No longer in shortage
OH gov. declares emergency
To hire 250,000 workers
Dream fire coach Wright
Golf Hall of Famer dies
5 Chinese nationals charged
Record heat bakes millions
US bans 2 Chinese firms
US diagnostic errors study
Fruit fly brain mapped
CA deepfakes law blocked
Weekly jobless claims rise
Israel strikes central Beirut
Disrupt Russian hackers
Expands online recruitment
Secures $4 billion credit line
Related topics
United States
Food and Drug Administration
Regeneron
Sanofi
Chronic obstructive pulmonary disease
Feedback